Amid flurry of financings for AAV plays, Dyno raises $100M series A led by a16z

The run of AAV company financings continues with Dyno’s $100 million series A round led by Andreessen Horowitz, which marks the third venture round for a capsid engineering company in eight days. 

Many of its competitors are developing their own gene therapy pipelines, but Dyno Therapeutics Inc.’s business model involves creating AAV vectors for partners. The new funding will advance its existing partnerships while allowing the company to take on new partners and expand the gene therapy technology into new target organs. ...